LONDON (Reuters) - U.S. regulators approved Shire's extended-release hyperactivity drug Intuniv and the product is expected to be available in U.S. pharmacies in November, the company said on Thursday ...
LONDON, July 28 (Reuters) - U.S. regulators have delayed approval of Shire's new extended-release hyperactivity drug Intuniv but the British company still expects it to be launched in the United ...
Alembic is launching Guanfacine Extended-Release tablets in dosage strengths of 1 mg, 2 mg, 3 mg and 4 mg. The product is the generic of Takeda’s Intuniv Extended-Release tablets. Guanfacine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results